These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24382605)

  • 21. Tuning the relaxation rates of dual-mode T(1)/T(2) nanoparticle contrast agents: a study into the ideal system.
    Keasberry NA; Bañobre-López M; Wood C; Stasiuk GJ; Gallo J; Long NJ
    Nanoscale; 2015 Oct; 7(38):16119-28. PubMed ID: 26371437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-circulating Gd(2)O(3):Yb(3+), Er(3+) up-conversion nanoprobes as high-performance contrast agents for multi-modality imaging.
    Liu Z; Pu F; Huang S; Yuan Q; Ren J; Qu X
    Biomaterials; 2013 Feb; 34(6):1712-21. PubMed ID: 23199744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.
    Yang H; Zhuang Y; Sun Y; Dai A; Shi X; Wu D; Li F; Hu H; Yang S
    Biomaterials; 2011 Jul; 32(20):4584-93. PubMed ID: 21458063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. L-DOPA-Coated Manganese Oxide Nanoparticles as Dual MRI Contrast Agents and Drug-Delivery Vehicles.
    McDonagh BH; Singh G; Hak S; Bandyopadhyay S; Augestad IL; Peddis D; Sandvig I; Sandvig A; Glomm WR
    Small; 2016 Jan; 12(3):301-6. PubMed ID: 26619158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of PEGylated KMnF3 nanoparticles as a T1-weighted contrast agent: chemical synthesis, in vivo brain MR imaging, and accounting for high relaxivity.
    Liu ZJ; Song XX; Tang Q
    Nanoscale; 2013 Jun; 5(11):5073-9. PubMed ID: 23640287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Folic acid-conjugated LaF3:Yb,Tm@SiO2 nanoprobes for targeting dual-modality imaging of upconversion luminescence and X-ray computed tomography.
    Ma J; Huang P; He M; Pan L; Zhou Z; Feng L; Gao G; Cui D
    J Phys Chem B; 2012 Dec; 116(48):14062-70. PubMed ID: 23134318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PEGylated NaHoF4 nanoparticles as contrast agents for both X-ray computed tomography and ultra-high field magnetic resonance imaging.
    Ni D; Zhang J; Bu W; Zhang C; Yao Z; Xing H; Wang J; Duan F; Liu Y; Fan W; Feng X; Shi J
    Biomaterials; 2016 Jan; 76():218-25. PubMed ID: 26546914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colloids containing gadolinium-capped gold nanoparticles as high relaxivity dual-modality contrast agents for CT and MRI.
    Zeng C; Shi X; Wu B; Zhang D; Zhang W
    Colloids Surf B Biointerfaces; 2014 Nov; 123():130-5. PubMed ID: 25260223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Marriage Strategy of Structure and Composition Designs for Intensifying Ultrasound & MR & CT Trimodal Contrast Imaging.
    Zhang K; Chen H; Li P; Bo X; Li X; Zeng Z; Xu H
    ACS Appl Mater Interfaces; 2015 Aug; 7(33):18590-9. PubMed ID: 26245739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upconverting rare-earth nanoparticles with a paramagnetic lanthanide complex shell for upconversion fluorescent and magnetic resonance dual-modality imaging.
    Wang Y; Ji L; Zhang B; Yin P; Qiu Y; Song D; Zhou J; Li Q
    Nanotechnology; 2013 May; 24(17):175101. PubMed ID: 23558298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contemporary applications and limitations of magnetic resonance imaging contrast materials.
    Natalin RA; Prince MR; Grossman ME; Silvers D; Landman J
    J Urol; 2010 Jan; 183(1):27-33. PubMed ID: 19913804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced dual contrast agent, Co(2+)-doped NaYF4:Yb(3+),Tm(3+) nanorods, for near infrared-to-near infrared upconversion luminescence and magnetic resonance imaging.
    Xia A; Zhang X; Zhang J; Deng Y; Chen Q; Wu S; Huang X; Shen J
    Biomaterials; 2014 Nov; 35(33):9167-76. PubMed ID: 25108318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnetite- and Iodine-Containing Nanoemulsion as a Dual Modal Contrast Agent for X-ray/Magnetic Resonance Imaging.
    Wallyn J; Anton N; Mertz D; Begin-Colin S; Perton F; Serra CA; Franconi F; Lemaire L; Chiper M; Libouban H; Messaddeq N; Anton H; Vandamme TF
    ACS Appl Mater Interfaces; 2019 Jan; 11(1):403-416. PubMed ID: 30541280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bifunctional Pyrrolidin-2-one Terminated Manganese Oxide Nanoparticles for Combined Magnetic Resonance and Fluorescence Imaging.
    Banerjee A; Bertolesi GE; Ling CC; Blasiak B; Purchase A; Calderon O; Tomanek B; Trudel S
    ACS Appl Mater Interfaces; 2019 Apr; 11(14):13069-13078. PubMed ID: 30883086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lanthanide ion-doped GdPO4 nanorods with dual-modal bio-optical and magnetic resonance imaging properties.
    Ren W; Tian G; Zhou L; Yin W; Yan L; Jin S; Zu Y; Li S; Gu Z; Zhao Y
    Nanoscale; 2012 Jun; 4(12):3754-60. PubMed ID: 22622654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nephrogenic systemic fibrosis versus contrast-induced nephropathy: risks and benefits of contrast-enhanced MR and CT in renally impaired patients.
    Martin DR; Semelka RC; Chapman A; Peters H; Finn PJ; Kalb B; Thomsen H
    J Magn Reson Imaging; 2009 Dec; 30(6):1350-6. PubMed ID: 19937934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biocompatible mesoporous silica-coated superparamagnetic manganese ferrite nanoparticles for targeted drug delivery and MR imaging applications.
    Sahoo B; Devi KS; Dutta S; Maiti TK; Pramanik P; Dhara D
    J Colloid Interface Sci; 2014 Oct; 431():31-41. PubMed ID: 24980623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of lanthanoids as X-ray contrast agents.
    Pietsch H; Jost G; Frenzel T; Raschke M; Walter J; Schirmer H; Hütter J; Sieber MA
    Eur J Radiol; 2011 Nov; 80(2):349-56. PubMed ID: 20006455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iron oxide/manganese oxide co-loaded hybrid nanogels as pH-responsive magnetic resonance contrast agents.
    Wang X; Niu D; Wu Q; Bao S; Su T; Liu X; Zhang S; Wang Q
    Biomaterials; 2015; 53():349-57. PubMed ID: 25890733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hybrid assemblies based on a gadolinium-containing polyoxometalate and a cationic polymer with spermine side chains for enhanced MRI contrast agents.
    Chai W; Wang S; Zhao H; Liu G; Fischer K; Li H; Wu L; Schmidt M
    Chemistry; 2013 Sep; 19(40):13317-21. PubMed ID: 24030934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.